RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to TYMS

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
CAPECITABINE	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	diffuse gastric adenocarcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Suspended	ClinicalTrials
FLOXURIDINE	Small molecule	intrahepatic cholangiocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	peritoneum cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	peritoneum cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
TEGAFUR	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	triple-negative breast cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neuroendocrine neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Lynch syndrome	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLOXURIDINE	Small molecule	carcinoid tumor	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	urothelial carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	Biphasic Mesothelioma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	urothelial carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	pancreatic neuroendocrine tumor	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Enrolling by invitation	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	4.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	esophageal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	metastasis	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	Sinonasal Undifferentiated Carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	neuroendocrine neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	0.5	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	digestive system cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	squamous cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	laryngeal neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	4.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	0.5	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
RALTITREXED	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	thymus cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	anal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	anal carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	meibomian cyst	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	urethra cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	metastasis	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	prostate cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	liver cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	Thymoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	liver cancer	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastrointestinal disease	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	Digestive System Carcinoma	Thymidylate synthase inhibitor	0.5	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	neuroendocrine neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colon adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	fallopian tube cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	renal pelvis/ureter urothelial carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
RALTITREXED	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	Digestive System Carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
TEGAFUR	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	prostate cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	glaucoma	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	upper aerodigestive tract neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	renal cell carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	actinic keratosis	Thymidylate synthase inhibitor	4.0	-	DailyMed
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	cervical cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	malignant tumor of extrahepatic bile duct	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
TEGAFUR	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	upper aerodigestive tract neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	0.5	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	neuroendocrine neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	liver cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	esophageal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	nasopharyngeal squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	peritoneum cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	Vitiligo	Thymidylate synthase inhibitor	4.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	bladder transitional cell carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	urothelial carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	Uveal Melanoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	squamous cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	HER2 Positive Breast Carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	bile duct cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	thyroid cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	basal cell carcinoma	Thymidylate synthase inhibitor	4.0	-	DailyMed
FLUOROURACIL	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	ampulla of Vater adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	Digestive System Carcinoma	Thymidylate synthase inhibitor	0.5	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	brain cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
NOLATREXED	Small molecule	liver cancer	Thymidylate synthase antagonist	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	pseudomyxoma peritonei	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenosquamous carcinoma	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Hepatoblastoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	neuroendocrine carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Suspended	ClinicalTrials
TEGAFUR	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	biliary tract neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	laryngeal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	cervical squamous cell carcinoma	Thymidylate synthase inhibitor	0.5	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
TEGAFUR	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	0.5	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	rectal neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	endometrial cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	malignant glioma	Thymidylate synthase inhibitor	0.5	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
TEGAFUR	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lymphoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	leptomeningeal metastasis	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	esophageal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Enrolling by invitation	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Suspended	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	non-Hodgkins lymphoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic endocrine carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastrointestinal disease	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
RALTITREXED	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	anus cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLOXURIDINE	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	intrahepatic cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	fallopian tube cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	adenosquamous lung carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	actinic keratosis	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	central nervous system non-hodgkin lymphoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	myelodysplastic syndrome	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	skin cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	4.0	-	DailyMed
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
RALTITREXED	Small molecule	Bile Duct Adenoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	bronchoalveolar adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	urogenital neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	kidney cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	large cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	metastasis	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
RALTITREXED	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	neuroendocrine carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
RALTITREXED	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	urinary bladder carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	0.5	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	3.0	Enrolling by invitation	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	renal cell carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	cancer	Thymidylate synthase inhibitor	3.0	Enrolling by invitation	ClinicalTrials
CAPECITABINE	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
RALTITREXED	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic endocrine carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
RALTITREXED	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	grade III glioma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neuroendocrine neoplasm	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	bladder tumor	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	Keloid	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	skin carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	osteosarcoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic melanoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	squamous cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
OSI-7904	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	large cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colonic neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	squamous cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
RALTITREXED	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	4.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	upper aerodigestive tract neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	metastasis	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
RALTITREXED	Small molecule	childhood acute lymphoblastic leukemia	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	1.0	Enrolling by invitation	ClinicalTrials
CAPECITABINE	Small molecule	lung cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	hypopharyngeal carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	liver cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	primary peritoneal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	upper aerodigestive tract neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colonic neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	digestive system cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	renal cell carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	intrahepatic cholangiocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Suspended	ClinicalTrials
FLUOROURACIL	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	large cell lung carcinoma	Thymidylate synthase inhibitor	4.0	-	DailyMed
CAPECITABINE	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	gallbladder cancer	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	0.5	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	gestational trophoblastic neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	glioblastoma multiforme	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	oral cavity cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
RALTITREXED	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	metastatic melanoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	4.0	-	DailyMed
TEGAFUR	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	Anal Squamous Cell Carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colon adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	urinary bladder cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	anus cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	oropharyngeal carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	metastasis	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	bone squamous cell carcinoma	Thymidylate synthase inhibitor	4.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic neuroendocrine tumor	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	peritoneum cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	colon mucinous adenocarcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	colon adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	cervical cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	glioblastoma multiforme	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	primary peritoneal carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	lymphoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
TEGAFUR	Small molecule	neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	sarcoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLOXURIDINE	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	non-Hodgkins lymphoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	dysplasia of cervix	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	endometrial cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	intrahepatic cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	actinic keratosis	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	prostate cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLOXURIDINE	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	glioblastoma multiforme	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	non-Hodgkins lymphoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	urinary bladder cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	liver cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
TEGAFUR	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	myelofibrosis	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	oral squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pterygium	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	Vitiligo	Thymidylate synthase inhibitor	4.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	bladder transitional cell carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Suspended	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	peritoneum cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	laryngeal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell squamous lung carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	4.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gallbladder cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	esophageal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	sarcoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	uterine neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
OSI-7904	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	central nervous system cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colon mucinous adenocarcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neuroendocrine neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	4.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	cutaneous melanoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	multiple myeloma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	bronchoalveolar adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
RALTITREXED	Small molecule	childhood acute myeloid leukemia	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	peritoneal neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	thyroid cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	nasal cavity and paranasal sinus squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	renal cell carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLOXURIDINE	Small molecule	fallopian tube cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	carcinoma	Thymidylate synthase inhibitor	0.5	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	0.5	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	urothelial carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	Hand-foot syndrome	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Suspended	ClinicalTrials
CAPECITABINE	Small molecule	liver cancer	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	Central Nervous System Neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	Digestive System Carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	renal pelvis/ureter urothelial carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	actinic keratosis	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	primary peritoneal carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	malignant tumor of extrahepatic bile duct	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gallbladder neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	neuroendocrine carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	4.0	-	DailyMed
PEMETREXED	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	renal cell carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Suspended	ClinicalTrials
PEMETREXED	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	urogenital neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	open-angle glaucoma	Thymidylate synthase inhibitor	4.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	keratosis	Thymidylate synthase inhibitor	4.0	-	DailyMed
FLUOROURACIL	Small molecule	inflammatory breast carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Anal Squamous Cell Carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	HER2 Positive Breast Carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLOXURIDINE	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	diffuse large B-cell lymphoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	digestive system neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
RALTITREXED	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	4.0	-	DailyMed
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
OSI-7904	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Digestive System Carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	cervical cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
TEGAFUR	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLOXURIDINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
RALTITREXED	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colonic neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	neuroendocrine neoplasm	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	gestational trophoblastic neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	neuroendocrine neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	gastric intestinal type adenocarcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Suspended	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLOXURIDINE	Small molecule	peritoneum cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gallbladder cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	carcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	3.0	Suspended	ClinicalTrials
FLUOROURACIL	Small molecule	urinary bladder cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	urethra cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colonic neoplasm	Thymidylate synthase inhibitor	4.0	-	DailyMed
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	0.5	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	glioma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	thrombotic disease	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	4.0	-	DailyMed
TEGAFUR	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	peritoneum cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	chronic myeloproliferative disorder	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	thyroid cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	squamous cell intraepithelial neoplasia	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	actinic keratosis	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLOXURIDINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastasis	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	Central Nervous System Lymphoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	Fallopian Tube Carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm of esophagus	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
RALTITREXED	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
RALTITREXED	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	ovarian carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Cervical Intraepithelial Neoplasia Grade 2/3	Thymidylate synthase inhibitor	0.5	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	renal cell carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
TEGAFUR	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	upper aerodigestive tract neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	Thymoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	cancer	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Suspended	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	Merkel cell skin cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	4.0	-	ATC
CAPECITABINE	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	cervical cancer	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	endometrial cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	oral squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLOXURIDINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	0.5	Completed	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	neoplasm	Thymidylate synthase inhibitor	4.0	-	ATC
PEMETREXED	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	Fallopian Tube Carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	Merkel cell skin cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	Oral leukoplakia	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLOXURIDINE	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
RALTITREXED	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
TEGAFUR	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	liver cancer	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	ovarian carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	upper aerodigestive tract neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	4.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	Thymic Carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
RALTITREXED	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	4.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
DOXIFLURIDINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	urinary bladder cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neuroendocrine carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Enrolling by invitation	ClinicalTrials
CAPECITABINE	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	inflammatory breast carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	urinary bladder cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	cervical cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colon adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	urinary bladder cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	liver cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	Digestive System Carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Suspended	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
RALTITREXED	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	skin carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	4.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lymphoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	kidney neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	upper aerodigestive tract neoplasm	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	Anal Squamous Cell Carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	peritoneum cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	hypopharyngeal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colon adenocarcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	fallopian tube cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLOXURIDINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	anus cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	peripheral neuropathy	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	triple-negative breast cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	Digestive System Carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	anus cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
RALTITREXED	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	renal cell carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-Hodgkins lymphoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
RALTITREXED	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	human papillomavirus-related squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	leukemia	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	melanoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	upper aerodigestive tract neoplasm	Thymidylate synthase inhibitor	4.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	Anal Squamous Cell Carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	Hepatoblastoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	cervical cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
RALTITREXED	Small molecule	neoplasm	Thymidylate synthase inhibitor	4.0	-	ATC
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck neoplasia	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
RALTITREXED	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	liver cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	inflammatory breast carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	peritoneal neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pterygium	Thymidylate synthase inhibitor	4.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	metastatic melanoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gallbladder neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic endocrine carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colon adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	glioma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLOXURIDINE	Small molecule	liver cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	rectal carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	signet ring cell carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	0.5	Terminated	ClinicalTrials
PEMETREXED	Small molecule	malignant peritoneal mesothelioma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	4.0	-	DailyMed
FLUOROURACIL	Small molecule	urothelial carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gallbladder carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	adenosquamous lung carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	laryngeal neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	basal cell carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	urinary bladder cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	primary peritoneal carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Suspended	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	biliary tract neoplasm	Thymidylate synthase inhibitor	2.0	Enrolling by invitation	ClinicalTrials
PEMETREXED	Small molecule	male breast carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	peritoneum cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	anus cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	renal cell carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	anus cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	gallbladder carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLOXURIDINE	Small molecule	intrahepatic cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
RALTITREXED	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	neuroendocrine neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	oral squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	anal neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic neuroendocrine tumor	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	0.5	Completed	ClinicalTrials
CAPECITABINE	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	small intestine carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	bladder transitional cell carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	digestive system neoplasm	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	cancer	Thymidylate synthase inhibitor	3.0	Enrolling by invitation	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Keloid	Thymidylate synthase inhibitor	4.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	sarcoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	brain disease	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	neuroendocrine neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	kidney cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	head and neck squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	brain cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	lymphoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	melanoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	male breast carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
RALTITREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	Vitiligo	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastasis	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	chordoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Thymidylate synthase inhibitor	4.0	-	ATC
CAPECITABINE	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	Fallopian Tube Carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	cervical cancer	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
TEGAFUR	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	4.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	ependymoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	liver cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	nasal cavity carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	urethra cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	ovarian carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	4.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	4.0	Not yet recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	urogenital neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
TEGAFUR	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	small intestinal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	fallopian tube cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	cervical cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	neoplasm of esophagus	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	cutaneous melanoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	medulloblastoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLOXURIDINE	Small molecule	small intestine cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	injury	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	male breast carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLOXURIDINE	Small molecule	primary peritoneal carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	bladder transitional cell carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	oropharynx squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	plantar wart	Thymidylate synthase inhibitor	4.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	cutaneous melanoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	hypopharyngeal carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	large cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	secondary malignant neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	nasal cavity and paranasal sinus carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
TEGAFUR	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	neoplasm	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	salivary gland carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	actinic keratosis	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	mesothelioma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	hypopharyngeal carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	oral squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
TEGAFUR	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	intrahepatic cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	renal cell carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	Central Nervous System Lymphoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	4.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
RALTITREXED	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	metastasis	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	Thymic Carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	kidney cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	lung cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	non-small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
RALTITREXED	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	1.0	Suspended	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	kidney cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	liver cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	1.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
FLUOROURACIL	Small molecule	pharynx cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	non-Hodgkins lymphoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenosquamous carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	esophageal squamous cell carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	gastrointestinal stromal tumor	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	malignant pleural mesothelioma	Thymidylate synthase inhibitor	4.0	-	FDA
FLUOROURACIL	Small molecule	actinic keratosis	Thymidylate synthase inhibitor	0.5	Completed	ClinicalTrials
TEGAFUR	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	anus cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	gallbladder carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	biliary tract cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
PEMETREXED	Small molecule	breast cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
TEGAFUR	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	lung cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	4.0	-	ATC
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
DOXIFLURIDINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastroesophageal junction adenocarcinoma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	esophageal cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLOXURIDINE	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLOXURIDINE	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	urinary bladder cancer	Thymidylate synthase inhibitor	2.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	Biphasic Mesothelioma	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Fibrolamellar Carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	salivary gland carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLOXURIDINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	neuroendocrine carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	neuroendocrine carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	gastrointestinal stromal tumor	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	malignant glioma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	4.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
TEGAFUR	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	glaucoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	ovarian cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	renal pelvis/ureter urothelial carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	mesothelioma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	cholangiocarcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	Undifferentiated Pancreatic Carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neuroendocrine carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic malignant neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
RALTITREXED	Small molecule	mesothelioma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	neoplasm	Thymidylate synthase inhibitor	4.0	-	ATC
PEMETREXED	Small molecule	small cell lung carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic carcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	triple-negative breast cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Hepatoblastoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Lymphoma, AIDS-Related	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	metastatic colorectal cancer	Thymidylate synthase inhibitor	3.0	Suspended	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	peritoneum cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLUOROURACIL	Small molecule	breast cancer	Thymidylate synthase inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Keloid	Thymidylate synthase inhibitor	4.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	Thymoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	rectum cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastric cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	lung neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
CAPECITABINE	Small molecule	cervical cancer	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
RALTITREXED	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	mucinous carcinoma	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	gastric adenocarcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic ductal adenocarcinoma	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	breast neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	Merkel cell skin cancer	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	hepatocellular carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	small intestine carcinoma	Thymidylate synthase inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	head and neck malignant neoplasia	Thymidylate synthase inhibitor	2.0	Withdrawn	ClinicalTrials
CAPECITABINE	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	4.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	breast carcinoma	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
PEMETREXED	Small molecule	squamous cell carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	anal neoplasm	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	stomach neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
RALTITREXED	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	pancreatic adenocarcinoma	Thymidylate synthase inhibitor	3.0	Recruiting	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
FLOXURIDINE	Small molecule	colorectal carcinoma	Thymidylate synthase inhibitor	3.0	Terminated	ClinicalTrials
CAPECITABINE	Small molecule	fallopian tube cancer	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials
PEMETREXED	Small molecule	cervical cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	gastric carcinoma	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
PEMETREXED	Small molecule	carcinoma	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
TEGAFUR	Small molecule	small cell lung carcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
RALTITREXED	Small molecule	nasopharyngeal neoplasm	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	upper aerodigestive tract neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	colorectal cancer	Thymidylate synthase inhibitor	1.0	Not yet recruiting	ClinicalTrials
RALTITREXED	Small molecule	rectum cancer	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	leptomeningeal metastasis	Thymidylate synthase inhibitor	1.0	Recruiting	ClinicalTrials
TEGAFUR	Small molecule	gastric cancer	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	cancer	Thymidylate synthase inhibitor	1.0	Completed	ClinicalTrials
PEMETREXED	Small molecule	lung adenocarcinoma	Thymidylate synthase inhibitor	2.0	Recruiting	ClinicalTrials
PEMETREXED DISODIUM	Small molecule	sarcoma	Thymidylate synthase inhibitor	2.0	Completed	ClinicalTrials
FLUOROURACIL	Small molecule	paranasal sinus neoplasm	Thymidylate synthase inhibitor	3.0	Completed	ClinicalTrials
CAPECITABINE	Small molecule	rectum cancer	Thymidylate synthase inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUOROURACIL	Small molecule	proliferative vitreoretinopathy	Thymidylate synthase inhibitor	3.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	hilar cholangiocarcinoma	Thymidylate synthase inhibitor	2.0	Not yet recruiting	ClinicalTrials
CAPECITABINE	Small molecule	intrahepatic cholangiocarcinoma	Thymidylate synthase inhibitor	1.0	Withdrawn	ClinicalTrials
PEMETREXED	Small molecule	cancer	Thymidylate synthase inhibitor	2.0	Unknown status	ClinicalTrials
FLUOROURACIL	Small molecule	malignant colon neoplasm	Thymidylate synthase inhibitor	2.0	Terminated	ClinicalTrials

Welcome to

RBP World!

Drugs target to TYMS

Targets details